| Literature DB >> 35633712 |
Dai Zhang1, Ran Qiang1, Zhijun Zhou2, Yang Pan1, Shuiqing Yu3, Wei Yuan1, Jianing Cheng4, Jinhui Wang1, Dongmei Zhao1, Jiehua Zhu1, Zhihui Yang1.
Abstract
Alternaria solani is an airborne fungus and the primary causal agent of potato early blight worldwide. No available fungicides that are both effective and environmentally friendly are usable to control this fungus. Therefore, biological control is a potential approach for its suppression. In this study, Bacillus subtilis strain ZD01's fermentation broth strongly reduced A. solani pathogenicity under greenhouse conditions. The effects of strain ZD01's secondary metabolites on A. solani were investigated. The exposure of A. solani hyphae to the supernatant resulted in swelling and swollen sacs, and the ZD01 supernatant reduced A. solani conidial germination significantly. Matrix-assisted laser desorption/ionization time of flight mass spectrometry and pure product tests revealed that fengycins were the main antifungal lipopeptide substances. To elucidate the molecular mechanism of the fengycins' biological control, RNA sequencing analyses were performed. A transcriptome analysis revealed that 304 and 522 genes in A. solani were differentially expressed after 2-h and 6-h fengycin treatments, respectively. These genes were respectively mapped to 53 and 57 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. In addition, the most enriched KEGG pathway analysis indicated that the inhibitory mechanisms of fengycins against A. solani regulated the expression of genes related to cell wall, cell membrane, transport, energy process, protein synthesis and genetic information. In particular, cell wall and cell membrane metabolism were the main processes affected by fengycin stress. Scanning and transmission electron microscope results revealed hyphal enlargement and a wide range of abnormalities in A. solani cells after exposure to fengycins. Furthermore, fengycins induced chitin synthesis in treated cells, and also caused the capture of cellular fluorescent green labeling and the release of adenosine triphosphate (ATP) from outer membranes of A. solani cells, which may enhance the fengycins ability to alter cell membrane permeability. Thus, this study increases the transcriptome data resources available and supplies a molecular framework for B. subtilis ZD01 inhibition of A. solani HWC-168 through various mechanisms, especially damaging A. solani cell walls and membranes. The transcriptomic insights may lead to an effective control strategy for potato early blight.Entities:
Keywords: Alternaria solani; Bacillus subtilis; cell wall and membrane; conidia; fengycins; transcriptome
Year: 2022 PMID: 35633712 PMCID: PMC9130778 DOI: 10.3389/fmicb.2022.861113
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 4Lipopeptides produced by ZD01 show antagonistic effects against the growth of A. solani HWC-168. (A) Colony morphology of A. solani co-cultured with ZD01 lipopeptides. (B) Optical and scanning electron micrographs of A. solani co-cultured with ZD01 lipopeptides. (C) Identification of ZD01 lipopeptides by MALDI-TOF-MS. (D) Colony morphology of A. solani co-cultured with fengycins and surfactins for the analysis of the active ingredients against A. solani. (E) Determination of the MIC value of fengycins against A. solani using the microdilution method. The red arrows indicate wrinkled surfaces hyphal cells treated with lipopeptides; the yellow arrows indicate the vacuolation of hyphae after exposure to lipopeptides.
FIGURE 1Biocontrol effects of B. subtilis ZD01 fermentation broth on the potato early blight in a pot assay under greenhouse conditions. (A) Effects of 5 × 103, 5 × 105, and 5 × 107 CFU/mL of B. subtilis ZD01 fermentation broth on the development of early blight symptoms of potato leaves. (B) The diseased leaf rate and lesion areas of potato leaves inoculated with A. solani HWC-168 with or without the ZD01 fermentation broth treatment. (C) Chlorophyll α fluorescence induction of a diseased potato leaf (kept in darkness for 20 min before the measurement). Data are presented as means of three replicates ± SDs, and error bars represent the SDs for three replicates. Means with different letters have significant differences (p < 0.05).
FIGURE 2Bacillus subtilis ZD01 significantly reduced the disease severity caused by A. solani HWC-168 on potato leaves in vivo. (A) Evidence of disease development on potato leaves treated with the ZD01supernatant, bacteria and fermentation broth prior to A. solani HWC-168 inoculation. (B) The lesion areas of potato leaves of potato inoculated with A. solani HWC-168 and co-cultured with ZD01 supernatant, bacteria and fermentation broth. (C) Quantitative detection by qPCR of A. solani HWC-168 growth on potato leaves inoculated with A. solani HWC-168 and co-cultured with the ZD01 supernatant, bacteria and fermentation broth. Data are presented as means of three replicates ± SDs, and error bars represent the SDs for three replicates. Means with different letters are significantly different (p < 0.05).
FIGURE 3Supernatant extracted from the ZD01 fermentation broth exhibited inhibitory effects on A. solani HWC-168 mycelial growth and conidial germination. (A) Effects of the supernatant produced by B. subtilis ZD01 on A. solani mycelial growth. (B) Optical and scanning electron micrographs of A. solani co-cultured with the ZD01 supernatant. (C,D) Reduction in conidial germination of A. solani treated with the ZD01 supernatant. Data are presented as means of three replicates ± SDs, and error bars represent the SDs for three replicates. Means with different letters are significantly different (p < 0.05).
Calculated mass values of M, M + H+, and M + Na+ ions corresponding to identified isoforms of surfactins and fengycins in culture extracts from B. subtilis ZD01.
| Lipopeptide | Mass value | ||
|
| |||
| M | M + H+ | M + Na+ | |
| Surfactin A (C13) | 1,007.6 | 1,008.6 | 1,030.6 |
| Surfactin B (C14) | 1,021.7 | 1,022.7 | 1,044.7 |
| Surfactin C (C15) | 1,035.7 | 1,036.7 | 1,058.7 |
| Fengycin A (C15/Ala-6) | 1,448.8 | 1,449.8 | 1,471.9 |
| Fengycin B (C16/Ala-6) | 1,462.9 | 1,463.9 | 1,485.9 |
| Fengycin C (C17/Ala-6) | 1,476.9 | 1,477.9 | 1,499.9 |
| Fengycin D (C16/Val-6) | 1,490.9 | 1,491.9 | 1,513.9 |
| Fengycin E (C17/Val-6) | 1,504.9 | 1,505.9 | 1,527.9 |
Profile of the transcriptome sequence data.
| Parameter | CK_2h | CK_6h | FenT_2h | FenT_6h |
| Raw reads (million) | 23.47 ± 0.68 | 22.63 ± 0.88 | 23.24 ± 0.62 | 23.15 ± 0.75 |
| Clean reads (million) | 23.00 ± 0.57 | 22.13 ± 0.84 | 22.75 ± 0.53 | 22.61 ± 0.82 |
| Clean bases (G) | 6.90 ± 0.17 | 6.64 ± 0.25 | 6.83 ± 0.16 | 6.79 ± 0.25 |
| Error (%) | 0.03 ± 0.01 | 0.03 ± 0.01 | 0.03 ± 0.00 | 0.03 ± 0.00 |
| Q20 (%) | 98.17 ± 0.48 | 97.96 ± 0.16 | 97.89 ± 0.08 | 97.96 ± 0.06 |
| Q30(%) | 94.56 ± 1.34 | 93.98 ± 0.30 | 93.86 ± 0.17 | 93.97 ± 0.11 |
| GC content (%) | 55.11 ± 0.10 | 55.01 ± 0.04 | 55.17 ± 0.03 | 54.81 ± 0.14 |
| Total mapped reads | 42550511(92.51 ± 0.12%) | 41277661(93.25 ± 0.38%) | 41906706(92.10 ± 0.28%) | 42061125(92.99 ± 0.33%) |
FIGURE 5Volcano plots, Venn diagrams, a heatmap and the GO functional classification. (A) The differences in the distribution and density distribution of gene expression in CK_2h, CK_6h, FenT_2h, and FenT_6h. (B) Venn diagrams showing the numbers of common DEGs that are shared in comparisons among CK_2h, CK_6h, FenT_2h, and FenT_6h. (C) Heatmap of the common DEGs in the three treatment groups. (D) GO functional classification results of DEGs shared by the three treatment groups. The DEGs were assigned to three categories: cellular component, molecular function and biological process.
Mostly enriched KEGG pathway of DEGs in A. solani.
| 2 h | 6 h | ||||||
|
| |||||||
| Pathway | Input number | Background number | Pathway ID | Pathway | Input number | Background number | Pathway ID |
| Fatty acid degradation | 4 | 10 | ko00071 | Proteasome | 4 | 8 | ko03050 |
| Tryptophan metabolism | 5 | 18 | ko00380 | mRNA surveillance pathway | 6 | 17 | ko03015 |
| RNA degradation | 4 | 14 | ko03018 | Steroid biosynthesis | 4 | 12 | ko00100 |
| Valine, leucine and isoleucine degradation | 3 | 10 | ko00280 | Aminoacyl-tRNA biosynthesis | 4 | 13 | ko00970 |
| DNA replication | 3 | 11 | ko03030 | Starch and sucrose metabolism | 8 | 33 | ko00500 |
| Propanoate metabolism | 2 | 7 | ko00640 | Amino sugar and nucleotide sugar metabolism | 6 | 24 | ko00520 |
| beta-Alanine metabolism | 3 | 15 | ko00410 | Spliceosome | 7 | 30 | ko03040 |
| Pyruvate metabolism | 2 | 10 | ko00620 | Galactose metabolism | 4 | 15 | ko00052 |
| Glycolysis/Gluconeogenesis | 3 | 19 | ko00010 | Nitrogen metabolism | 2 | 6 | ko00910 |
| RNA polymerase | 2 | 11 | ko03020 | Methane metabolism | 2 | 6 | ko00680 |
| Basal transcription factors | 2 | 11 | ko03022 | Glutathione metabolism | 3 | 11 | ko00480 |
| Purine metabolism | 4 | 29 | ko00230 | Basal transcription factors | 3 | 11 | ko03022 |
| Steroid biosynthesis | 2 | 12 | ko00100 | Meiosis - yeast | 5 | 22 | ko04113 |
| Pyrimidine metabolism | 3 | 22 | ko00240 | Ubiquitin mediated proteolysis | 5 | 24 | ko04120 |
| Arginine and proline metabolism | 2 | 14 | ko00330 | Glycolysis/Gluconeogenesis | 4 | 19 | ko00010 |
| Protein export | 1 | 5 | ko03060 | Ether lipid metabolism | 2 | 8 | ko00565 |
| Ascorbate and aldarate metabolism | 1 | 5 | ko00053 | Endocytosis | 6 | 31 | ko04144 |
| Cysteine and methionine metabolism | 1 | 5 | ko00270 | Arginine and proline metabolism | 3 | 14 | ko00330 |
| Amino sugar and nucleotide sugar metabolism | 3 | 24 | ko00520 | Glycerophospholipid metabolism | 4 | 20 | ko00564 |
| Phenylalanine metabolism | 2 | 15 | ko00360 | Pentose phosphate pathway | 2 | 9 | ko00030 |
| Nitrogen metabolism | 1 | 6 | ko00910 | Fructose and mannose metabolism | 2 | 9 | ko00051 |
| Methane metabolism | 1 | 6 | ko00680 | Histidine metabolism | 2 | 9 | ko00340 |
| Lysine degradation | 2 | 16 | ko00310 | Phenylalanine metabolism | 3 | 15 | ko00360 |
| Nucleotide excision repair | 2 | 17 | ko03420 | Cell cycle - yeast | 5 | 28 | ko04111 |
| Arginine biosynthesis | 1 | 8 | ko00220 | Fatty acid degradation | 2 | 10 | ko00071 |
| Ether lipid metabolism | 1 | 8 | ko00565 | Mismatch repair | 2 | 10 | ko03430 |
| Pentose and glucuronate interconversions | 2 | 19 | ko00040 | Purine metabolism | 5 | 29 | ko00230 |
| Endocytosis | 3 | 31 | ko04144 | MAPK signaling pathway - yeast | 5 | 30 | ko04011 |
| Pentose phosphate pathway | 1 | 9 | ko00030 | Sphingolipid metabolism | 2 | 11 | ko00600 |
| Butanoate metabolism | 1 | 9 | ko00650 | RNA polymerase | 2 | 11 | ko03020 |
| Glycerolipid metabolism | 1 | 9 | ko00561 | Tyrosine metabolism | 3 | 18 | ko00350 |
| Histidine metabolism | 1 | 9 | ko00340 | Tryptophan metabolism | 3 | 18 | ko00380 |
| Mismatch repair | 1 | 10 | ko03430 | Sulfur metabolism | 1 | 5 | ko00920 |
| RNA transport | 3 | 34 | ko03013 | Selenocompound metabolism | 1 | 5 | ko00450 |
| Oxidative phosphorylation | 2 | 23 | ko00190 | Alanine, aspartate and glutamate metabolism | 2 | 13 | ko00250 |
| Protein processing in endoplasmic reticulum | 3 | 35 | ko04141 | Cyanoamino acid metabolism | 1 | 6 | ko00460 |
| Sphingolipid metabolism | 1 | 11 | ko00600 | ABC transporters | 1 | 6 | ko02010 |
| Glutathione metabolism | 1 | 11 | ko00480 | Phenylalanine, tyrosine and tryptophan biosynthesis | 1 | 6 | ko00400 |
| Ribosome biogenesis in eukaryotes | 2 | 26 | ko03008 | RNA transport | 5 | 34 | ko03013 |
| Aminoacyl-tRNA biosynthesis | 1 | 13 | ko00970 | Ribosome | 2 | 14 | ko03010 |
| Ribosome | 1 | 14 | ko03010 | Protein processing in endoplasmic reticulum | 5 | 35 | ko04141 |
| Cell cycle - yeast | 2 | 28 | ko04111 | Homologous recombination | 1 | 7 | ko03440 |
| Galactose metabolism | 1 | 15 | ko00052 | Phagosome | 2 | 15 | ko04145 |
| Phagosome | 1 | 15 | ko04145 | Regulation of mitophagy - yeast | 2 | 15 | ko04139 |
| Inositol phosphate metabolism | 1 | 15 | ko00562 | Oxidative phosphorylation | 3 | 23 | ko00190 |
| Peroxisome | 1 | 16 | ko04146 | Arginine biosynthesis | 1 | 8 | ko00220 |
| mRNA surveillance pathway | 1 | 17 | ko03015 | Peroxisome | 2 | 16 | ko04146 |
| Tyrosine metabolism | 1 | 18 | ko00350 | Lysine degradation | 2 | 16 | ko00310 |
| Starch and sucrose metabolism | 2 | 33 | ko00500 | Nucleotide excision repair | 2 | 17 | ko03420 |
| Glycerophospholipid metabolism | 1 | 20 | ko00564 | Butanoate metabolism | 1 | 9 | ko00650 |
| Meiosis - yeast | 1 | 22 | ko04113 | Ribosome biogenesis in eukaryotes | 3 | 26 | ko03008 |
| Ubiquitin mediated proteolysis | 1 | 24 | ko04120 | Pyruvate metabolism | 1 | 10 | ko00620 |
| Spliceosome | 1 | 30 | ko03040 | Pentose and glucuronate interconversions | 2 | 19 | ko00040 |
| DNA replication | 1 | 11 | ko03030 | ||||
| Pyrimidine metabolism | 2 | 22 | ko00240 | ||||
| beta-Alanine metabolism | 1 | 15 | ko00410 | ||||
| Inositol phosphate metabolism | 1 | 15 | ko00562 | ||||
| Glycine, serine and threonine metabolism | 1 | 17 | ko00260 | ||||
FIGURE 6Effects of fengycins on A. solani hyphal cell wall integrity and cell membrane permeability. (A) Scanning and transmission electron micrographs of A. solani hyphae co-cultured with fengycins. (B) Chitin contents of A. solani hyphae co-cultured with fengycins and a control groups. (C) Fluorescence microscope imaging of A. solani hyphae treated with fengycins and a control groups. The phase channel shows all the fungal cells in bright-field images, and the Sytox Green channel shows cells attached or inserted with Sytox Green labeling; the merged channel shows the proportion of Sytox Green-labeled cells. (D) Effects of fengycins on ATP release from A. solani. The changes in the extracellular ATP levels of A. solani represent cell membrane damage. The results are presented as the means ± SDs (n = 3).
FIGURE 7Effects of fengycins on conidial germination and structure. (A,B) Reduction in the conidial germination of A. solani after treatment with fengycins. (C) Transmission electron micrographs of A. solani co-cultured with fengycins. Data are presented as means of three replicates ± SDs, and error bars represent the SDs for three replicates. Means with different letters are significantly different (p < 0.05).
FIGURE 8A model for the mode of action of fengycins produced by ZD01 against A. solani. Fengycins produced by ZD01 mediate A. solani mycelial growth and conidial germination. Fengycins damage the cell wall integrity, change mycelial cell membrane permeability and alter conidial structures, which subsequently leads to the suppression of fungal growth, mycelial penetration, conidial vitality and germination. Therefore, A. solani fails to infect potato leaves.